European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Osteoporos Int. 2013 Jan;24(1):23-57. doi: 10.1007/s00198-012-2074-y. Epub 2012 Oct 19.

Abstract

Guidance is provided in a European setting on the assessment and treatment of postmenopausal women at risk of fractures due to osteoporosis.

Introduction: The International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis published guidance for the diagnosis and management of osteoporosis in 2008. This manuscript updates these in a European setting.

Methods: Systematic literature reviews.

Results: The following areas are reviewed: the role of bone mineral density measurement for the diagnosis of osteoporosis and assessment of fracture risk, general and pharmacological management of osteoporosis, monitoring of treatment, assessment of fracture risk, case finding strategies, investigation of patients and health economics of treatment.

Conclusions: A platform is provided on which specific guidelines can be developed for national use.

Publication types

  • Practice Guideline

MeSH terms

  • Absorptiometry, Photon
  • Age Distribution
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Bone Density / physiology
  • Bone Density Conservation Agents / therapeutic use
  • Drug Monitoring / methods
  • Europe / epidemiology
  • Female
  • Hip Fractures / epidemiology
  • Hip Fractures / etiology
  • Hip Fractures / prevention & control
  • Humans
  • Medication Adherence
  • Middle Aged
  • Osteoporosis, Postmenopausal / complications
  • Osteoporosis, Postmenopausal / diagnosis*
  • Osteoporosis, Postmenopausal / drug therapy*
  • Osteoporosis, Postmenopausal / epidemiology
  • Osteoporotic Fractures / epidemiology
  • Osteoporotic Fractures / etiology
  • Osteoporotic Fractures / prevention & control
  • Risk Assessment / methods

Substances

  • Biomarkers
  • Bone Density Conservation Agents